[Corrections] Correction to Lancet Infect Dis 2024; published online Aug 12. https://doi.org/10.1016/S1473-3099(24)00357-8

Di |2024-08-28T00:30:01+02:00Agosto 28th, 2024|Categorie: Coronavirus Lancet|

McMahon R, Toepfer S, Sattler N, et al. Antibody persistence and safety of a live-attenuated chikungunya virus vaccine up to 2 years after single-dose administration in adults in the USA: a single-arm, multicentre, phase 3b study. Lancet Infect Dis 202...

[Correspondence] Oropouche fever: reports of vertical transmission and deaths in Brazil

Di |2024-08-23T00:30:01+02:00Agosto 23rd, 2024|Categorie: Coronavirus Lancet|

Brazil has seen an alarming increase in cases of Oropouche fever, an emerging arboviral disease caused by the Oropouche virus, which has sparked public health concerns due to the first confirmed reports of deaths and vertical transmission. This situati...

[Correspondence] Studies of post-exposure prophylaxis with doxycycline should consider population-level selection for antimicrobial resistance

Di |2024-08-22T00:30:01+02:00Agosto 22nd, 2024|Categorie: Coronavirus Lancet|

In their recent Article,1 Jean-Michel Molina and colleagues provide not only further evidence of the efficacy of doxycycline post-exposure prophylaxis (PEP) but also novel data showing that doxycycline PEP does not select for methicillin-resistant Stap...

[Comment] Re-evaluating polio vaccination strategies in Nepal: transitioning from OPV to fIPV for sustained immunity

Di |2024-08-22T00:30:01+02:00Agosto 22nd, 2024|Categorie: Coronavirus Lancet|

In 2014, WHO declared Nepal polio-free.1 However, recent detections of vaccine-derived poliovirus type-3 (VDPV3) in sewage samples from the Tukucha and Bagmati rivers have raised concerns.2 Similar detections were reported in Israel and Palestine betwe...

[Correspondence] The global alarm bell is ringing due to the threat of potential severe cases and deaths caused by clade I of monkeypox virus

Di |2024-08-21T00:30:01+02:00Agosto 21st, 2024|Categorie: Coronavirus Lancet|

WHO reported that as of the end of June, 2024, the multicountry mpox outbreak had caused a total of 99 176 laboratory-confirmed cases.1 The WHO has proposed developing mpox control and elimination plans from 2024 to 2025 in the Strategic Framework for ...

[Articles] Effectiveness of rVSV-ZEBOV vaccination during the 2018–20 Ebola virus disease epidemic in the Democratic Republic of the Congo: a retrospective test-negative study

Di |2024-08-21T00:30:01+02:00Agosto 21st, 2024|Categorie: Coronavirus Lancet|

This analysis is the first to provide estimates of the real-world effectiveness of the rVSV-ZEBOV vaccine against Ebola virus disease, amid the widespread use of the vaccine during a large Ebola virus disease outbreak. Our findings confirm that rVSV-ZE...

[Articles] Effectiveness of rVSV-ZEBOV vaccination during the 2018–20 Ebola virus disease epidemic in the Democratic Republic of the Congo: a retrospective test-negative study

Di |2024-08-21T00:30:01+02:00Agosto 21st, 2024|Categorie: Coronavirus Lancet|

This analysis is the first to provide estimates of the real-world effectiveness of the rVSV-ZEBOV vaccine against Ebola virus disease, amid the widespread use of the vaccine during a large Ebola virus disease outbreak. Our findings confirm that rVSV-ZE...

[Correspondence] The global alarm bell is ringing due to the threat of potential severe cases and deaths caused by clade I of monkeypox virus

Di |2024-08-21T00:30:01+02:00Agosto 21st, 2024|Categorie: Coronavirus Lancet|

WHO reported that as of the end of June, 2024, the multicountry mpox outbreak had caused a total of 99 176 laboratory-confirmed cases.1 The WHO has proposed developing mpox control and elimination plans from 2024 to 2025 in the Strategic Framework for ...

Torna in cima